Author

Srikanth Basety

Observed name: Basety, Srikanth

Institution: Tris Pharma (United States)

Observed institution: Tris Pharma (United States)

ORCID: 0009-0007-1491-7687

Observed ORCID: 0009-0007-1491-7687

OpenAlex ID: A5120867499

Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery

2026 · Srikanth Basety, Renuka Gudepu, et al. · Pharmaceutics · 15

Artificial Intelligence in Lung Cancer: A Narrative Review of Recent Advances in Diagnosis, Biomarker Discovery, and Drug Development

2026 · Srikanth Basety, Renuka Gudepu, et al. · Pharmaceutics · 8

Formulation and Characterization of Lycopene‐Loaded Microemulsion‐based Gel for the Management of Chronic Wound Healing

2025 · Pankaj Popli, Inderjeet Singh, et al. · Advanced Therapeutics · 4

Aloe-emodin microemulsion gel for diabetic wounds: optimizing surfactant–polymer synergy for effective wound management

2026 · Pankaj Popli, Sakshi Gaur, et al. · Therapeutic Delivery · 1

Eco-friendly selenium nanoparticles using Cymbopogon citratus: a multifunctional therapeutic agent with low toxicity

2026 · Renuka Gudepu, Subhashini Vedala, et al. · Inorganic Chemistry Communications

Aloe-emodin microemulsion gel for diabetic wounds: optimizing surfactant–polymer synergy for effective wound management

2026 · Popli, Pankaj, Gaur, Sakshi, et al. · Figshare

Works count: 6

Citation count: 28

H-index: 3

I10-index: 1